LIFELONG BLEEDING DIATHESIS - EFFECT OF ORTHOTOPIC LIVER-TRANSPLANTATION

被引:3
作者
HUMPHRIES, JE
GONIAS, SL
PIZZO, SV
WILLIAMS, ME
机构
[1] UNIV VIRGINIA, SCH MED, DEPT INTERNAL MED, CHARLOTTESVILLE, VA USA
[2] UNIV VIRGINIA, SCH MED, DEPT BIOCHEM, CHARLOTTESVILLE, VA USA
[3] DUKE UNIV, DEPT PATHOL, DURHAM, NC 27706 USA
[4] DUKE UNIV, DEPT BIOCHEM, DURHAM, NC 27706 USA
关键词
TISSUE-TYPE PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR-1; FIBRINOLYSIS; LIVER TRANSPLANTATION; CIRRHOSIS; HEMORRHAGE; ANTIFIBRINOLYTIC AGENT;
D O I
10.1093/ajcp/102.6.816
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proper regulation of the fibrinolytic system is critical to the prevention of both thrombosis and hemorrhage. Patients with inherited or acquired excess fibrinolysis may have a bleeding tendency, usually characterized by delayed and posttrauma or postoperative bleeding. The liver plays many roles in this regulation, including the synthesis of plasminogen, alpha(2)-antiplasmin (alpha(2)AP) and plasminogen activator inhibitor-1 (PAI-1), and the clearance of tissue-plasminogen activator (t-PA). Inherited deficiencies of a(2)AP, PAI-1, and inherited excess t-PA associated with clinically significant bleeding have been reported. The authors describe a patient with a life-long bleeding diathesis who demonstrated evidence of excess t-PA. One of two daughters also had a bleeding tendency and demonstrated excess t-PA. The patient developed cirrhosis and underwent orthotopic liver transplantation. Following transplantation, all fibrinolytic parameters returned to normal, and the bleeding diathesis appeared to no longer exist. The effect of liver transplantation on this patient's fibrinolytic abnormalities and the effect of cirrhosis on this patient's laboratory evaluation are discussed.
引用
收藏
页码:816 / 820
页数:5
相关论文
共 43 条
[31]  
MAKRIS M, 1991, BR J HAEMATOL S1, V77, P2
[32]   ALPHA-ANTIPLASMIN AND DISSEMINATED INTRAVASCULAR COAGULATION IN LIVER-CIRRHOSIS [J].
MARONGIU, F ;
MAMUSA, AM ;
MAMELI, G ;
MULAS, G ;
SOLINAS, A ;
DEMELIA, L ;
CONTU, L .
THROMBOSIS RESEARCH, 1985, 37 (02) :287-294
[33]  
MERION RM, 1988, SURGERY, V104, P929
[34]   FIBRINOLYSIS AND ACQUIRED ALPHA-2 PLASMIN INHIBITOR DEFICIENCY IN AMYLOIDOSIS [J].
MEYER, K ;
WILLIAMS, EC .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (03) :394-396
[35]  
MILES LA, 1982, BLOOD, V59, P1246
[36]  
NGUYEN G, 1988, BLOOD, V72, P601
[37]   THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) PHASE-II PILOT-STUDY - TISSUE PLASMINOGEN-ACTIVATOR FOLLOWED BY PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].
PASSAMANI, E ;
HODGES, M ;
HERMAN, M ;
GROSE, R ;
CHAITMAN, B ;
ROGERS, W ;
FORMAN, S ;
TERRIN, M ;
KNATTERUD, G ;
ROBERTSON, T ;
BRAUNWALD, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) :B51-B64
[38]  
PIZZO SV, 1986, ARCH PATHOL LAB MED, V110, P517
[39]   COMPARATIVE-STUDY OF THE FIBRINOLYTIC SYSTEM IN HUMAN FETUSES AND IN PREGNANT-WOMEN [J].
REVERDIAUMOALIC, P ;
GRUEL, Y ;
DELAHOUSSE, B ;
RUPIN, A ;
HUART, MC ;
BODY, G ;
LEROY, J .
THROMBOSIS RESEARCH, 1991, 61 (5-6) :489-499
[40]   BLEEDING DIATHESIS DUE TO DECREASED FUNCTIONAL-ACTIVITY OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR [J].
SCHLEEF, RR ;
HIGGINS, DL ;
PILLEMER, E ;
LEVITT, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1747-1752